PALISADE CAPITAL MANAGEMENT, LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 42 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,000,000
-12.0%
1,173,0000.0%0.03%
-15.2%
Q2 2018$1,136,000
+5.7%
1,173,0000.0%0.03%
-8.3%
Q1 2018$1,075,000
+6.8%
1,173,0000.0%0.04%
+5.9%
Q4 2017$1,007,000
-4.9%
1,173,0000.0%0.03%
-10.5%
Q3 2017$1,059,000
+5.0%
1,173,0000.0%0.04%0.0%
Q2 2017$1,009,000
+1.3%
1,173,0000.0%0.04%0.0%
Q1 2017$996,000
+11.5%
1,173,0000.0%0.04%
+11.8%
Q4 2016$893,000
-7.2%
1,173,000
-0.3%
0.03%0.0%
Q3 2016$962,000
-11.7%
1,176,000
-5.3%
0.03%
-15.0%
Q2 2016$1,089,000
-1.4%
1,242,0000.0%0.04%
+11.1%
Q1 2016$1,105,000
-18.6%
1,242,000
+5.4%
0.04%
-18.2%
Q4 2015$1,358,000
+20.1%
1,178,000
-5.1%
0.04%
+33.3%
Q3 2015$1,131,000
-74.0%
1,241,000
-71.1%
0.03%
-70.0%
Q2 2015$4,343,000
+436.8%
4,297,000
+443.2%
0.11%
+450.0%
Q1 2015$809,000
+112.9%
791,000
+139.7%
0.02%
+122.2%
Q4 2014$380,000
+11.1%
330,0000.0%0.01%0.0%
Q3 2014$342,000330,0000.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Opti Capital Management, LP 7,500$6,276,0002.99%
PFM Health Sciences, LP 90,886,000$75,652,0002.01%
Jabre Capital Partners S.A. 1,750,000$1,474,0001.68%
Partner Investment Management, L.P. 1,108,000$922,0001.15%
Telemetry Investments, L.L.C. 2,000,000$1,655,0001.06%
Worth Venture Partners, LLC 1,562,000$1,312,0000.99%
DLD Asset Management, LP 12,000,000$10,028,0000.69%
Castle Creek Arbitrage, LLC 2,310,000$1,937,0000.67%
CANYON CAPITAL ADVISORS LLC 28,775,000$23,830,0000.56%
SYMPHONY ASSET MANAGEMENT LLC 2,000,000$1,665,0000.49%
View complete list of ACORDA THERAPEUTICS INC shareholders